Royal Bank of Canada’s Orexigen Therapeutics, Inc. OREX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-184
| Closed | – | – | 6385 |
|
|
2018
Q1 | $0 | Sell |
184
-13,667
| -99% | – | ﹤0.01% | 6407 |
|
|
2017
Q4 | $18K | Buy |
13,851
+11,667
| +534% | +$15.2K | ﹤0.01% | 4903 |
|
|
2017
Q3 | $5K | Sell |
2,184
-142
| -6% | -$325 | ﹤0.01% | 5690 |
|
|
2017
Q2 | $7K | Sell |
2,326
-504
| -18% | -$1.52K | ﹤0.01% | 5210 |
|
|
2017
Q1 | $10K | Buy |
2,830
+2,287
| +421% | +$8.08K | ﹤0.01% | 5317 |
|
|
2016
Q4 | $1K | Sell |
543
-147
| -21% | -$271 | ﹤0.01% | 5826 |
|
|
2016
Q3 | $2K | Sell |
690
-30
| -4% | -$87 | ﹤0.01% | 5470 |
|
|
2016
Q2 | $3K | Sell |
720
-110
| -13% | -$458 | ﹤0.01% | 5392 |
|
|
2016
Q1 | $5K | Sell |
830
-359
| -30% | -$2.16K | ﹤0.01% | 5243 |
|
|
2015
Q4 | $20K | Sell |
1,189
-1,105
| -48% | -$18.6K | ﹤0.01% | 4974 |
|
|
2015
Q3 | $48K | Buy |
2,294
+142
| +7% | +$2.97K | ﹤0.01% | 4574 |
|
|
2015
Q2 | $107K | Buy |
2,152
+602
| +39% | +$29.9K | ﹤0.01% | 4312 |
|
|
2015
Q1 | $121K | Sell |
1,550
-15,927
| -91% | -$1.24M | ﹤0.01% | 4073 |
|
|
2014
Q4 | $1.06M | Buy |
17,477
+423
| +2% | +$25.6K | ﹤0.01% | 2395 |
|
|
2014
Q3 | $726K | Buy |
17,054
+1,566
| +10% | +$66.7K | ﹤0.01% | 2635 |
|
|
2014
Q2 | $957K | Buy |
15,488
+1,646
| +12% | +$102K | ﹤0.01% | 2462 |
|
|
2014
Q1 | $900K | Buy |
13,842
+1,360
| +11% | +$88.4K | ﹤0.01% | 2446 |
|
|
2013
Q4 | $703K | Sell |
12,482
-1,576
| -11% | -$88.8K | ﹤0.01% | 2615 |
|
|
2013
Q3 | $862K | Buy |
14,058
+12,408
| +752% | +$761K | ﹤0.01% | 2433 |
|
|
2013
Q2 | $97K | Buy |
+1,650
| New | +$97K | ﹤0.01% | 3762 |
|